Skip to Main Content

Paper Details

Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.
Proc Natl Acad Sci U S A
14
2020
CLCF1, CNTFR, IL-6, IL-6 family cytokine ligand, Interleukin-6, LIFR, atherosclerosis, cancer, cardiotrophin-like cytokine factor 1, ciliary neurotrophic factor receptor, glycoprotein 130, gp130, leukemia inhibitory factor receptor, nonsmall cell lung cancer, osteoporosis, tumor
Author NameAffiliation
E Alejandro Sweet-CorderoUniversity of California san francisco
E Alejandro Sweet-CorderoUniversity of California san francisco
  • 1 - 2

Datasets

Release 1.2